PUBLISHER: The Business Research Company | PRODUCT CODE: 1810954
PUBLISHER: The Business Research Company | PRODUCT CODE: 1810954
Medical specimen tracking systems are digital tools designed to oversee and control the collection, labeling, transport, testing, and storage of biological specimens-such as blood, tissue, or urine-throughout diagnostic or research workflows. These systems often employ barcodes, RFID, or cloud-based platforms to ensure accurate traceability. The core objective of medical specimen tracking systems is to preserve specimen integrity, reduce errors, and enhance workflow efficiency within laboratories and healthcare settings.
The primary product categories in medical specimen tracking systems include software, hardware, and consumables. Software in these systems refers to digital platforms and applications used to manage, track, and document the status and movement of biological samples. These systems are utilized in various areas such as patient testing, clinical trials, and tissue specimen management, supported by technologies like radio frequency identification and barcode tracking. They are applied in settings such as diagnostics, biobanking, and clinical and research trials, serving a broad range of end users including hospitals and clinics, pathology laboratories, and other healthcare organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The medical specimen tracking systems market research report is one of a series of new reports from The Business Research Company that provides medical specimen tracking systems market statistics, including medical specimen tracking systems industry global market size, regional shares, competitors with a medical specimen tracking systems market share, detailed medical specimen tracking systems market segments, market trends and opportunities, and any further data you may need to thrive in the medical specimen tracking systems industry. This medical specimen tracking systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical specimen tracking systems market size has grown strongly in recent years. It will grow from $1.06 billion in 2024 to $1.15 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to the rising demand for precise diagnostic testing, expansion of laboratory automation, development of hospital infrastructure, a surge in medical error occurrences, and an increasing number of clinical trials.
The medical specimen tracking systems market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing hospital admission rates, a rising number of surgical procedures, a growing focus on precision medicine, continued reliance on manual specimen tracking approaches, and an increasing number of pathology laboratories. Major trends in the forecast period include technological progress, advancements in mobile-compatible specimen tracking, enhanced integration with electronic health records, development of systems for temperature-sensitive tracking, innovation in real-time location monitoring, and improvements in automating chain-of-custody processes.
The increasing focus on precision medicine is expected to drive the growth of the medical specimen tracking systems market going forward. Precision medicine is a healthcare approach that tailors disease prevention and treatment based on an individual's genetic profile, environment, and lifestyle. This approach is gaining momentum due to the expanding availability of genomic data, which enables healthcare providers to create targeted treatments based on a person's unique genetic characteristics, resulting in more effective care. Medical specimen tracking systems facilitate precision medicine by ensuring accurate and timely handling of biological samples, which guarantees reliable diagnostic data for personalized treatment plans. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Thus, the growing emphasis on precision medicine is boosting the medical specimen tracking systems market.
Key players in the medical specimen tracking systems market are concentrating on technological advancements like cloud-based digital solutions to improve specimen traceability, minimize errors, and enhance efficiency in laboratory workflows across various healthcare environments. Cloud-based digital solutions allow remote access, storage, and management of data and operations through internet-hosted platforms. For instance, in May 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced Navify Sample Tracking, a digital system designed to help laboratories track patient test samples effectively throughout the diagnostic process. This solution improves transparency and traceability, reduces errors, shortens turnaround times, and streamlines communication between healthcare providers and laboratories. Navify Sample Tracking also integrates smoothly with existing laboratory infrastructure, offering real-time status updates and customizable alerts, thereby boosting operational efficiency and patient safety.
In February 2022, MLM Medical Labs, a Germany-based leading specialty and central laboratory, partnered with TruLab GmbH for an undisclosed amount. This partnership aims to extend MLM Medical Labs' geographic presence and strengthen its operational capabilities in clinical trial support across Europe. TruLab Inc. is a US-based technology company specializing in real-time biological sample tracking.
Major players in the medical specimen tracking systems market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Zebra Technologies Corporation, Brooks Automation Inc., Cryoport Systems LLC, Peak Technologies Inc., LabWare Inc., LabConnect LLC, Orchard Software Corporation, STARLIMS Corporation, LabLynx Inc., RMS Omega Technologies Group Inc., CrelioHealth, BSI Life Sciences, OpenSpecimen, GAO Group Inc., Taylor Data Systems Inc., NovoPath LLC, Comp Pro Med Inc., Specimen Track LLC.
North America was the largest region in the medical specimen tracking systems market in 2024. The regions covered in medical specimen tracking systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the medical specimen tracking systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical specimen tracking systems market consists of revenues earned by entities providing services such as real-time sample tracking, temperature monitoring, and customizable workflow management. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical specimen tracking systems market also includes sales of medical instrument, collection boxes, injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Specimen Tracking Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medical specimen tracking systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical specimen tracking systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical specimen tracking systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.